Murat Kalayoglu

Insider Reports History

Location
Washington, DC
Signature
/s/ Murat Kalayoglu
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Murat Kalayoglu:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cartesian Therapeutics, Inc. 10%+ Owner Common Stock 5,313,261 $38,308,611 $7.21 02 Apr 2026 by trust
Cartesian Therapeutics, Inc. 10%+ Owner Common Stock 506,999 $3,655,462 $7.21 02 Apr 2026 Direct
Cartesian Therapeutics, Inc. 10%+ Owner Stock Option (Right to Buy) 7,800 $6,162 $0.7900 02 Jan 2026 Direct
Cartesian Therapeutics, Inc. 10%+ Owner Series A Non-Voting Convertible Preferred Stock 33,662 02 Apr 2026 by trust

Insider Reports Filed by Murat Kalayoglu

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RNAC Cartesian Therapeutics, Inc. 02 Apr 2026 2 $0 4 10%+ Owner 06 Apr 2026, 16:28
RNAC Cartesian Therapeutics, Inc. 02 Jan 2026 2 $0 4 Director, 10%+ Owner 06 Jan 2026, 16:18
RNAC Cartesian Therapeutics, Inc. 02 Jan 2025 2 $0 4 Director, 10%+ Owner 06 Jan 2025, 16:20
RNAC Cartesian Therapeutics, Inc. 11 Oct 2024 2 $0 4 Director, 10%+ Owner 15 Oct 2024, 16:53
RNAC Cartesian Therapeutics, Inc. 08 Apr 2024 4 $0 4 Director, 10%+ Owner 10 Apr 2024, 21:43
RNAC Cartesian Therapeutics, Inc. 02 Jan 2024 2 $0 4 Director, 10%+ Owner 04 Jan 2024, 17:04
RNAC Cartesian Therapeutics, Inc. 13 Nov 2023 5 +$154,906,738 4 Director, 10%+ Owner 15 Nov 2023, 16:41
RNAC Cartesian Therapeutics, Inc. 13 Nov 2023 0 $0 3 Director, 10%+ Owner 15 Nov 2023, 16:37
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .